PL4048284T4 - Metoda leczenia nowotworów - Google Patents

Metoda leczenia nowotworów

Info

Publication number
PL4048284T4
PL4048284T4 PL20878437.1T PL20878437T PL4048284T4 PL 4048284 T4 PL4048284 T4 PL 4048284T4 PL 20878437 T PL20878437 T PL 20878437T PL 4048284 T4 PL4048284 T4 PL 4048284T4
Authority
PL
Poland
Prior art keywords
treating cancers
cancers
treating
Prior art date
Application number
PL20878437.1T
Other languages
English (en)
Other versions
PL4048284T3 (pl
Inventor
Hung-Kun Hsu
Original Assignee
Acura Nanomedicine Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acura Nanomedicine Corporation filed Critical Acura Nanomedicine Corporation
Publication of PL4048284T3 publication Critical patent/PL4048284T3/pl
Publication of PL4048284T4 publication Critical patent/PL4048284T4/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41681,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47064-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20878437.1T 2019-10-21 2020-10-20 Metoda leczenia nowotworów PL4048284T4 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962923631P 2019-10-21 2019-10-21
US201962923629P 2019-10-21 2019-10-21
PCT/CN2020/122269 WO2021078126A1 (en) 2019-10-21 2020-10-20 Method for treating cancers

Publications (2)

Publication Number Publication Date
PL4048284T3 PL4048284T3 (pl) 2025-11-03
PL4048284T4 true PL4048284T4 (pl) 2025-11-03

Family

ID=75619656

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20878437.1T PL4048284T4 (pl) 2019-10-21 2020-10-20 Metoda leczenia nowotworów

Country Status (11)

Country Link
US (1) US12419864B2 (pl)
EP (1) EP4048284B1 (pl)
JP (1) JP7568309B2 (pl)
KR (1) KR20220066938A (pl)
CN (1) CN114585369B (pl)
AU (1) AU2020369741B2 (pl)
CA (1) CA3157841A1 (pl)
ES (1) ES3035147T3 (pl)
PL (1) PL4048284T4 (pl)
TW (1) TWI826738B (pl)
WO (1) WO2021078126A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114601833A (zh) * 2022-04-02 2022-06-10 北京大学口腔医学院 一种治疗肿瘤的化学药物组合
WO2024242538A1 (ko) * 2023-05-19 2024-11-28 국립암센터 이버멕틴 및 항암제를 포함하는 암 예방 또는 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1830847B1 (en) * 2004-12-06 2014-11-19 Pitney Pharmaceuticals Pty Limited Treatment for cancer
US8962614B2 (en) * 2008-04-17 2015-02-24 The Johns Hopkins University ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors
CN104164471A (zh) * 2013-11-04 2014-11-26 复旦大学 基于细胞自噬的抗肿瘤药物的筛选方法

Also Published As

Publication number Publication date
PL4048284T3 (pl) 2025-11-03
AU2020369741A1 (en) 2022-05-12
JP2022553298A (ja) 2022-12-22
CA3157841A1 (en) 2021-04-29
KR20220066938A (ko) 2022-05-24
CN114585369A (zh) 2022-06-03
AU2020369741B2 (en) 2024-06-13
EP4048284A4 (en) 2023-11-01
US20220387391A1 (en) 2022-12-08
TWI826738B (zh) 2023-12-21
WO2021078126A1 (en) 2021-04-29
NZ787377A (en) 2025-02-28
TW202128151A (zh) 2021-08-01
EP4048284A1 (en) 2022-08-31
EP4048284C0 (en) 2025-03-19
JP7568309B2 (ja) 2024-10-16
CN114585369B (zh) 2024-09-13
US12419864B2 (en) 2025-09-23
ES3035147T3 (en) 2025-08-29
EP4048284B1 (en) 2025-03-19

Similar Documents

Publication Publication Date Title
IL287907A (en) Cancer treatment methods
IL304275A (en) Cancer treatment methods
ZA201706616B (en) Method for treating cancer
IL290454A (en) Method of treating kras-associated cancers
EP3641770A4 (en) CANCER TREATMENT METHODS
IL312680A (en) Cancer treatment methods
IL257691A (en) A method for treating cancer
IL280128A (en) A method for treating epilepsy
IL291565A (en) A method for treating phenylalanine irregularity
EP3946287A4 (en) METHOD OF TREATMENT OF CANCER WITH TOZADENANT
EP3988175A4 (en) Method for treating malignant tumor
IL289811A (en) A method for treating cancer
IL280800A (en) A method for treating pancreatic cancer
SG11202010528XA (en) Combinations for treating cancer
PL3638630T3 (pl) Sposób obróbki szlamu
IL287210A (en) Preparations for the treatment of tumors
IL281167A (en) Kits and methods for cancer treatment
PL4048284T3 (pl) Metoda leczenia nowotworów
GB201909468D0 (en) Compounds for treating cancer
IL284668A (en) Methods of treating schizophrenia
EP4003390A4 (en) METHOD FOR TREATING SOLID TUMORS
EP3247376A4 (en) Method for treating cancer
SG10201508795XA (en) Method for treating cancer
GB2590648B (en) Radiotherapy apparatus
GB201909466D0 (en) Compounds for treating cancer